<DOC>
	<DOCNO>NCT01804790</DOCNO>
	<brief_summary>National , multi-center , open-label , randomize , 2-arm phase III superiority trial , compare neoadjuvant chemotherapy ( CT ) mFolfirinox follow preoperative chemoradiotherapy ( CRT ) , versus preoperative CRT patient locally advanced rectal cancer .</brief_summary>
	<brief_title>Phase III Study Comparing Preoperative Chemoradiotherapy Alone Versus Neoadjuvant Chemotherapy With Folfirinox Regimen Followed Preoperative Chemoradiotherapy Patients With Resectable Locally Advanced Rectal Cancer</brief_title>
	<detailed_description>Methodology This biomedical research , national , multicenter , open-label randomize , 2-arm phase III superiority trial , compare neoadjuvant CT mFolfirinox preoperative CRT , versus immediate preoperative CRT , patient locally advanced rectal cancer Randomized Phase III study stop rule Stratification : center , gender , tumor location rectum ( &lt; 6 cm anal verge versus â‰¥ 6 cm ) , initial stage ( cT3 v cT4 , cN0 v cN+ )</detailed_description>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Leucovorin</mesh_term>
	<criteria>Histogically proven rectal adenocarcinoma Stages cT3 risk local recurrence cT4 , M0 multidisciplinary meeting recommend preoperative CRT Resectable tumor , consider potentially resectable CRT No distant metastasis Patient eligible surgery Patient age 18 75 year WHO/ECOG performance status 0/2 . No heart failure coronary heart disease symptom ( even control ) . No peripheral neuropathy &gt; grade 1 No prior radiotherapy pelvis reason previous CT No major comorbidity may preclude delivery treatment active infection ( HIV chronic hepatitis B C ) . Adequate contraception fertile patient . Adequate hematologic function Adequate hepatic function Signed write informed consent Metastatic disease Unresectable rectal cancer , include prostatic involvement extension pelvic floor muscle Contraindication 5FU , oxaliplatin irinotecan , include Gilbert disease genotype UGT1A1 Medical history chronic diarrhea inflammatory disease colon rectum Medical history angina pectoris myocardial infarction Progressive active infection severe medical condition could jeopardize treatment administration Other concomitant cancer , medical history cancer treat situ cervical carcinoma basocellular carcinoma spinocellular carcinoma Patient include another clinical trial test investigational agent . Pregnant breastfeed woman . Persons deprive liberty guardianship incapable give consent Any psychological , familial , sociological geographical condition potentially hamper compliance study protocol followup schedule .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>rectum</keyword>
	<keyword>cancer</keyword>
	<keyword>locally advanced</keyword>
</DOC>